Recent Progress in the Pathogenesis of Nephrotic Proteinuria

REFERENCES

• Kestila M, Lenkkeri U, Mannikko M, Lameerin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan C E, Peltonen L, Holmberg C, Olsen A, Tryggvason K. Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575–582
   PubMed Web of Science ®Google Scholar
• Orth S R, Ritz E. The nephrotic syndrome. N Engl J Med 1998; 338: 1202–1211
   PubMed Web of Science ®Google Scholar
• Tesar V, Zima T, Kalousova M. Pathobiochemistry of nephrotic syndrome. Adv Clin Biochem 2002; 37: 173–218
   Google Scholar
• Smithies O. Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function. Proc Natl Acad Sci USA 2003; 100: 4108–4113
   PubMed Web of Science ®Google Scholar
• Deen W M. What determines glomerular capillary permeability?. J Clin Invest 2004; 114: 1412–1414
   PubMed Web of Science ®Google Scholar
• Guasch A, Myers B D. Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy. J Am Soc Nephrol 1994; 4: 1571–1581
   PubMedGoogle Scholar
• D'Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003; 63: 809–825
   PubMed Web of Science ®Google Scholar
• Van d en, Born J, van den Heuvel L P, Bakker M A, Veerkamp J H, Assmann K J, Berden J H. A monoclonal antibody against GBM heparan sulfate induces an acute selectve proteinuria in rats. Kidney Int 1992; 41: 115–123
   PubMedGoogle Scholar
• Kawachi H, Kurihara H, Topham P S, Brown D, Shia M A, Orikasa M, Shimizu F, Salant D J. Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol 1997; 273: F984–F993
   PubMedGoogle Scholar
• Caulfield J P, Farquhar M P. The permeability of glomerular capillaries to graded dextrans: identification of the basement membrane as the primary filtration barrier. J Cell Biol 1974; 63: 883–903
   PubMed Web of Science ®Google Scholar
• Kanwar Y S, Liu Z Z, Kashihara N, Wallner E I. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 1991; 11: 390–413
   PubMed Web of Science ®Google Scholar
• Rossi M, Morita H, Sormunen R, Airenne S, Kreivi M, Wang L, Fukai N, Olsen B R, Tryggvason K, Soininen R. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J 2003; 22: 236–245
   PubMed Web of Science ®Google Scholar
• Jarad G, Cunningham J, Shaw A S, Miner J H. Proteinuria precedes podocyte abnormalities in Lamb2−/− mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 2006; 116: 2272–2279
   PubMed Web of Science ®Google Scholar
• Farquhar M G. The glomerular basement membrane: not gone, just forgotten. J Clin Invest 2006; 116: 2090–2093
   PubMedGoogle Scholar
• Yoshioka N, Ito H, Akamatsu R, Hazikano H, Okada S, Matsuo T. Glomerular podocyte vacuolation in focal segmental glomerulosclerosis. Arch Pathol Lab Med 1986; 110: 394–398
   PubMedGoogle Scholar
• Eyre J, Ioannou K, Grubb B D, Saleem M A, Mathieson P W, Brunskill N J, Christensen E I, Topham P S. Statin-sensitive endocytosis of albumin by glomerular podocytes. Am J Physiol Renal Physiol 2007; 292: F674–F681
   PubMed Web of Science ®Google Scholar
• Bulger R E, Eknoyan G, Purcell D J, Dobyan D C. Endothelial characteristic of glomerular capillaries in normal, mercuric-chloride-induced, and gentamicin-induced acute renal failure in the rat. J Clin Invest 1983; 72: 128–141
   PubMedGoogle Scholar
• Sawada H, Stukenbrok H, Kerjaschki D, Farquhar M G. Epithelial polyanion (podocalyxin) is found on the sides but not the soles of the foot processes of the glomerular epithelium. Am J Pathol 1986; 125: 309–318
   PubMedGoogle Scholar
• Eremina V, Quaggin S E. The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 2004; 13: 9–15
   PubMed Web of Science ®Google Scholar
• Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber H P, Kikkawa Y, Miner J H, Quaggin S E. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707–716
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278: 12605–12608
   PubMed Web of Science ®Google Scholar
• Kalluri R. Proteinuria with and without renal glomerular podocyte effacement. J Am Soc Nephrol 2006; 17: 2383–2389
   PubMedGoogle Scholar
• Hudson B G, Reeder S T, Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993; 268: 26033–26036
   PubMed Web of Science ®Google Scholar
• Tryggvason K, Wartiovara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001; 10: 543–549
   PubMed Web of Science ®Google Scholar
• Badens C, Praga M, Tazón B, Heidet L, Arrondel C, Armengol A, Andrés A, Morales E, Camacho A, Lens X, Dávila S, Mila M, Antignac C, Darnell A, Torra R. Mutations in the COL4A4 and COL4A3 genes cause familial benign hematuria. J Am Soc Nephrol 2002; 13: 1248–1254
   PubMedGoogle Scholar
• Noakes P G, Miner J H, Gautam M, Cunningham J M, Sanes J R, Merlie J P. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet 1995; 10: 400–406
   PubMed Web of Science ®Google Scholar
• Dandapani S V, Pollak M R. The glomerular filter: biologic and genetic complexity. Kidney Int 2006; 70: 980–982
   PubMedGoogle Scholar
• Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher W, Maruniak-Chudek I, Lennert T, Neumann L M, Reis A. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004; 13: 2625–2632
   PubMed Web of Science ®Google Scholar
• Hasselbacher K, Wiggins R C, Matejas V, Hinkes B G, Mucha B, Hoskins B E, Ozaltin F, Nurnberg G, Becker C, Hangan D, Pohl M, Kuwertz-Broking E, Griebel M, Schumacher V, Royer-Pokora B, Bakkaloglu A, Nurnberg P, Zenker M, Hildebrandt F. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int 2006; 70: 1008–1012
   PubMed Web of Science ®Google Scholar
• Kanwar Y S, Farquhar M G. Presence of heparan sulfate in the glomerular basement membrane. Proc Natl Acad Sci USA 1979; 76: 1303–1307
   PubMed Web of Science ®Google Scholar
• Hassel J R, Robey P G, Barrach H J, Wilczek J, Rennard S I, Martin G R. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci USA 1980; 77: 4494–4498
   PubMed Web of Science ®Google Scholar
• Groffen A J, Ruegg M A, Dijkman H, van de Velden T J, Buskens C A, van den Born J, Assmann K J, Monnens L A, Veerkamp J H, van den Heuvel L P. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem 1998; 46: 19–27
   PubMed Web of Science ®Google Scholar
• Rops A L, van der Vlag J, Lensen J E, Wijnhoven T J, van den Heuvel L P, van Kuppevelt T H, Berden J H. Heparan sulfate proteglycans in glomerular inflammation. Kidney Int 2004; 65: 768–785
   PubMed Web of Science ®Google Scholar
• Kanwar Y S, Linker A, Farquhar M G. Increased permeability of the glomerular basement membrane in aminonucleoside nephrosis. J Cell Biol 1980; 86: 688–693
   PubMed Web of Science ®Google Scholar
• Caulfield J P, Farquhar M G. Loss of anionic sites from the glomerular basement membrane in aminonucleoside nephrosis. Lab Invest 1978; 39: 505–512
   PubMed Web of Science ®Google Scholar
• Harvey S J, Miner J. Podocyte-derive agrin is responsible for glomerular basement membrane anionic charge. J Am Soc Nephrol 2005; 16: 1A, abstract
   Google Scholar
• Morita H, Yoshimura A, Inui K, Ideura T, Watanabe H, Wang L, Soininen R, Tryggvason K. Heparan sulfate of perlecan is involved in glomerular filtration. J Am Soc Nephrol 2005; 16: 1703–1710
   PubMed Web of Science ®Google Scholar
• Russo L M, Bakris G L, Comper W D. Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 2002; 39: 899–919
   PubMed Web of Science ®Google Scholar
• Pavenstädt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253–307
   PubMed Web of Science ®Google Scholar
• Marshall C B, Shankland S J. Cell cycle and glomerular disease: a minireview. Nephron Exp Nephrol 2006; 102: e39–e48
   PubMedGoogle Scholar
• Kriz W, Hackenthal E, Nobiling R, Sakai T, Elger M, Hahnel B. A role for podocytes to counteract capillary wall distention. Kidney Int 1994; 45: 369–376
   PubMedGoogle Scholar
• Shankland S J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131–2147
   PubMed Web of Science ®Google Scholar
• Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10: 51–61
   PubMed Web of Science ®Google Scholar
• Schmieder S, Nagai M, Orlando R A, Takeda T, Farquhar M G. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and ezrin in MCDK cells. J Am Soc Nephrol 2004; 15: 2289–2298
   PubMedGoogle Scholar
• Orlando R A, Takeda T, Zak B, Schmieder S, Benoit V M, McQuistan T, Furthmayr H, Farquhar M G. The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol 2001; 12: 1589–1598
   PubMedGoogle Scholar
• Takeda T, McQuistan T, Orlando R A, Farquhar M G. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 2001; 108: 289–301
   PubMedGoogle Scholar
• Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D. Podoplanin, a novel 43-kd membrane protein of glomerular epithelial cells, is downregulated in puromycin nephrosis. Am J Pathol 1997; 151: 1141–1152
   PubMed Web of Science ®Google Scholar
• Farquhar M, Saito A, Kerjaschki D, Orlando R A. The Heymann nephritis antigenic complex: Megalin (gp330) and RAP. J Am Soc Nephrol 1995; 6: 35–47
   PubMed Web of Science ®Google Scholar
• Kriz W, Elger M, Mundel P, Lemley K V. Structure-stabilizing forces in the glomerular tuft. J Am Soc Nephrol 1995; 5: 1731–1739
   PubMedGoogle Scholar
• Endlich N, Kress K R, Reiser J, Uttenweiler D, Kriz W, Mundel P, Endlich K. Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 2001; 12: 413–422
   PubMed Web of Science ®Google Scholar
• Endlich N, Endlich K. Stretch, tension and adhesion – adaptive mechanisms of the actin cytoskeleton in podocytes. Eur J Cell Biol 2006; 85: 229–234
   PubMed Web of Science ®Google Scholar
• Morton M J, Hutchinson K, Mathieson P W, Witherden I R, Saleem M A, Hunter M. Human podocytes possess a stretch-sensitive, Ca2 +-activated K+ channel: potential implications for the control of glomerular filtration. J Am Soc Nephrol 2004; 15: 2981–2987
   PubMedGoogle Scholar
• Reiser J, Polu K R, Moller C C, Kenlan P, Altintas M M, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith P L, Clapham D E, Pollak M R. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37: 739–744
   PubMed Web of Science ®Google Scholar
• Winn M P, Conlon P J, Lynn K L, Farrington M K, Creazzo T, Hawkins A F, Daskalakis N, Kwan S Y, Ebersviller S, Burchette J L, Pericak-Vance M A, Howell D N, Vance J M, Resonberg P B. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801–1804
   PubMed Web of Science ®Google Scholar
• Huber T B, Gloy J, Henger A, Schollmeyer P, Greger R, Mundel P, Pavenstadt H. Catecholamines modulate podocyte function. J AmSoc Nephrol 1998; 9: 335–345
   PubMedGoogle Scholar
• Sharma R, Lovell H B, Wiegmann T B, Savin V J. Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells. J Am Soc Nephrol 1992; 3: 1131–1138
   PubMedGoogle Scholar
• Pavenstädt H. The charge for going by foot: modifying the surface of podocytes. Exp Nephrol 1998; 6: 98–103
   PubMedGoogle Scholar
• Rodriguez O C, Schaefer A W, Mandato C A, Forscher P, Bement W M, Waterman-Storer C M. Conserved microtubule-actin interactions in cell movement and morphogenesis. Nature Cell Biol 2003; 5: 599–609
   PubMed Web of Science ®Google Scholar
• Gao S Y, Li C Y, Chen J, Pan L, Saito S, Terashita T, Saito K, Miyawaki K, Shigemoto K, Mominoki K, Matsuda S, Kobayashi N. Rho-ROCK signal pathway regulates microtubule-based process formation of cultured podocytes – inhibition of ROCK promoted process elongation. Nephron Exp Nephrol 2004; 97: e49–e61
   PubMedGoogle Scholar
• Cybulsky A V, Carbonetto S, Huang Q, McTavish A J, Cyr M D. Adhesion of rat glomerular epithelial cells to extracellular matrices. Role of β 1 integrins. Kidney Int 1992; 42: 1099–1106
   PubMed Web of Science ®Google Scholar
• Kojima K, Davidovits A, Poczewski H, Langer B, Uchida S, Nagy-Bojarski K, Hovorka A, Sedivy R, Kerjaschki D. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction. J Am Soc Nephrol 2004; 15: 2079–2089
   PubMedGoogle Scholar
• Teixeira V, Blattner S M, Li M, Anders H J, Cohen C D, Edenhofer I, Calvaresi N, Merkle M, Rastaldi M P, Kretzler M. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005; 67: 514–523
   PubMedGoogle Scholar
• Critchley D R. Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. Biochem Soc Trans 2004; 32: 831–836
   PubMed Web of Science ®Google Scholar
• Kreidberg J A. Podocyte differentiation and glomerulogenesis. J Am Soc Nephrol 2003; 14: 806–814
   PubMedGoogle Scholar
• Usui J, Kurihara H, Shu Y, Tomari S, Kanemoto K, Koyama A, Sakai T, Takahashi T, Nagata M. Localization of intercellular adherens junction protein p120 catenin during podocyte differentiation. Anat Embryol 2003; 206: 175–184
   PubMedGoogle Scholar
• Takeda T, Go W Y, Orlando R A, Farquhar M G. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell 2000; 11: 3219–3232
   PubMed Web of Science ®Google Scholar
• Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006; 354: 1387–1401
   PubMed Web of Science ®Google Scholar
• Moeller M J. Dynamics at the slit diaphragm – is nephrin actin?. Nephrol Dial Transplant 2007; 22: 37–39
   PubMedGoogle Scholar
• Andrews P M. Investigations of cytoplasmic contractile and cytoskeletal elements in the kidney glomerulus. Kidney Int 1981; 20: 549–562
   PubMedGoogle Scholar
• Shirato I, Sakai T, Kimura K, Tomino Z, Kriz W. Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. Am J Pathol 1996; 148: 1283–1296
   PubMed Web of Science ®Google Scholar
• Reiser J, Oh J, Shirato I, Asanuma K, Hug A, Mundel T M, Honey K, Ishidoh K, Kominami E, Kreidberg J A, Tomino Y, Mundel P. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and α 3 integrin. J Biol Chem 2004; 279: 34827–34832
   PubMed Web of Science ®Google Scholar
• Kerjaschki D. Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001; 108: 1583–1587
   PubMed Web of Science ®Google Scholar
• Karumanchi S A, Maynard S E, Stillman I E, Epstein F H, Sukhatme V P. Preeclampsia: a renal perspective. Kidney Int 2005; 67: 2101–2113
   PubMed Web of Science ®Google Scholar
• Van d en, Berg J G, Weerman M A, Assmann K J, Weening J J, Florquin S. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 2004; 66: 1901–1906
   PubMedGoogle Scholar
• Garovic V C, Wagner S J, Petrovic L M, Gray C E, Hall P, Sugimoto H, Kalluri R, Grande J P. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 2007; 22: 1136–1143
   PubMed Web of Science ®Google Scholar
• Yu Y, Leng C G, Kato Y, Ohno S. Ultrastructural study of glomerular capillary loops at different perfusion pressures as revealed by quick-freezing, freeze-substitution and conventional fixation methods. Nephron 1997; 76: 452–459
   PubMedGoogle Scholar
• Rodewald R, Karnovsky M J. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol 1974; 60: 621–624
   Google Scholar
• Kurihara H, Anderson J M, Farquhar M G. Diversity among tight junctions in rat kidney: Glomerular slit diaphragms and endothelial junctions express only one isoform of the tight junction protein ZO-1. Proc Natl Acad Sci USA 1992; 89: 7075–7079
   PubMedGoogle Scholar
• Reiser J, Kriz W, Kretzler M, Mundel P. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000; 11: 1–8
   PubMed Web of Science ®Google Scholar
• Yaoita E, Yao J, Yoshida Y, Morioka T, Nameta M, Takata T, Kamiie J, Fujinaka H, Oite T, Yamamoto T. Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol 2002; 161: 1597–1606
   PubMedGoogle Scholar
• Saez J C, Berthoud V M, Branes M C, Martinez A D, Beyer E C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003; 83: 1359–1400
   PubMed Web of Science ®Google Scholar
• Silverstein D M, Urban M, Gao Y, Mattoo T K, Spray D C, Rozental R. Renal morphology in connexin43 knockout mice. Pediatr Nephrol 2001; 16: 467–471
   PubMedGoogle Scholar
• Sawai K, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Yoshioka T, Takeda R, Sugawara A, Kuwahara T, Saleem M A, Ogawa O, Nakao K. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy. Nephrol Dial Transplant 2006; 21: 2472–2477
   PubMedGoogle Scholar
• Orikasa M, Matsui K, Oite T, Shimizu F. Massive proteinuria induced in rats by a single intravenous injection of a monoclonal antibody. J Immunol 1988; 141: 807–814
   PubMedGoogle Scholar
• Kawachi H, Abrahamson D R, John P L, Goldstein D J, Shia M A, Matsui K, Shimizu F, Salant D J. Developmental expression of the nephritogenic antigen of monoclonal antibody 5-1-6. Am J Pathol 1995; 147: 823–833
   PubMedGoogle Scholar
• Topham P S, Kawachi H, Haydar S A, Chugh S, Addona T A, Charron K B, Holzman L B, Shia M, Shimizu F, Salant D J. Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 1999; 104: 1559–1566
   PubMedGoogle Scholar
• Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 1999; 10: 2440–2445
   PubMed Web of Science ®Google Scholar
• Tryggvason K, Ruotsalainen V, Wartiovaara J. Discovery of the congenital nephrotic syndrome gene discloses the structure of the mysterious molecular sieve of the kidney. Int J Dev Biol 1999; 43: 445–451
   PubMedGoogle Scholar
• Putaala H, Soininen R, Klipelainen P, Wartiovaara J, Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001; 10: 1–8
   PubMed Web of Science ®Google Scholar
• Wang S X, Ahola H, Palmen T, Solin M L, Luimula P, Holthofer H. Recurrence of nephrotic syndrome after transplantation in CNF is due to autoantibodies to nephrin. Exp Nephrol 2001; 9: 327–331
   PubMedGoogle Scholar
• Wartiovaara J, Ofverstedt L G, Khoshnoodi J, Zhang J, Makela E, Sandin S, Ruotsalainen V, Cheng R H, Jalanko H, Skoglund U, Tryggvason K. Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 2004; 114: 1475–1483
   PubMed Web of Science ®Google Scholar
• Doublier S, Ruotsalainen V, Salvidio G, Lupia E, Biancone L, Conaldi P G, Reponen P, Tryggvason K, Camussi G. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 2001; 158: 1723–1731
   PubMedGoogle Scholar
• Patari A, Forsblom C, Havana M, Taipale H, Groop P H, Holthofer H. Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 2003; 52: 2969–2974
   PubMed Web of Science ®Google Scholar
• Han Y P, Tuan T L, Wu H, Hughes M, Garner W L. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 2001; 114: 131–139
   PubMed Web of Science ®Google Scholar
• Takano Y, Yamauchi K, Hiramatsu N, Kasai A, Hayakawa K, Yokouchi M, Yao J, Kitamura M. Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin. Am J Physiol Renal Physiol 2007; 292: F1573–F1582
   PubMedGoogle Scholar
• Takano Y, Yamauchi K, Hayakawa K, Hiramatsu N, Kasai A, Okamura M, Yokouchi M, Shitamura A, Yao J, Kitamura M. Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett 2007; 581: 421–426
   PubMed Web of Science ®Google Scholar
• Donoviel D B, Freed D D, Vogel H, Potter D G, Hawkins E, Barrish J P, Mathur B N, Turner C A, Geske R, Montgomery C A, Starbuck M, Brandt M, Gupta A, Ramirez-Solis R, Zambrowicz B P, Powell D R. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to nephrin. Mol Cell Biol 2001; 21: 4829–4836
   PubMed Web of Science ®Google Scholar
• Gerke P, Sellin L, Kretz O. NEPH2 is located at the glomerular slit diaphragm, interacts with nephrin and is cleaved from podocytes by metalloproteinases. J Am Soc Nephrol 2005; 16: 1693–1702
   PubMed Web of Science ®Google Scholar
• Michaud J L, Kennedy C R. The podocyte in health and disease: insights from the mouse. Clin Sci 2007; 112: 325–335
   Google Scholar
• Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler M D, Niaudet P, Antignac C. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24: 349–354
   PubMed Web of Science ®Google Scholar
• Schwarz K, Simons M, Reiser J, Saleem M A, Faul C, Kriz W, Shaw A S, Holzman L B, Mundel P. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001; 108: 1621–1629
   PubMed Web of Science ®Google Scholar
• Harder T. Lipid raft domains and protein networks in T-cell receptor signal transduction. Curr Opin Immunol 2004; 16: 353–359
   PubMed Web of Science ®Google Scholar
• Luimula P, Sandstrom N, Novikov D, Holthofer H. Podocytes-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002; 82: 713–718
   PubMedGoogle Scholar
• Miner J H, Morello R, Andrews K L, Li C, Antignac C, Shaw A S, Lee B. Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J Clin Invest 2002; 109: 1065–1072
   PubMedGoogle Scholar
• Dustin M L, Olszowy M W, Holdorf A D, Li J, Bromley S, Desai N, Widder P, Rosenberger F, van der Merwe P A, Allen P M, Shaw A S. A novel adaptor protein orchestrates receptor patterning and cytoskeleletal polarity in T-cell contacts. Cell 1998; 94: 667–677
   PubMed Web of Science ®Google Scholar
• Shih N Y, Li J, Karpitskij V, Nguyen A, Dustin M L, Kanagawa O, Miner J H, Shaw A S. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999; 286: 312–315
   PubMed Web of Science ®Google Scholar
• Tossidou I, Kardinal C, Peters I, Kriz W, Shaw A, Dikic I, Tkachuk S, Dumler I, Haller H, Schiffer M. CD2AP/CIN85 balance determines RTK-signaling response in podocytes. J Biol Chem 2007; 282: 7457–7464
   PubMedGoogle Scholar
• Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 2004; 15: 1382–1391
   PubMed Web of Science ®Google Scholar
• Patrakka J, Xiao Z, Nukui M, Takemoto M, He L, Oddsson A, Perisic L, Kaukinen A, Al-Khalili A, Szigyarto C, Uhlén M, Jalanko H, Betsholtz C, Tryggvason K. Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, Ehd3, Sh2d4a, Plekhh2, and 2310066E14Rik. J Am Soc Nephrol 2007; 18: 689–697
   PubMedGoogle Scholar
• Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi M P, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe A H, Kreidberg J A, Mundel P. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390–1397
   PubMed Web of Science ®Google Scholar
• Lahdenpera J, Kilpelainen P, Liu X L, Pikkarainen T, Reponen P, Ruotsalainen V, Tryggvason K. Clustering-induced tyrosine phosphorylation of nephrin by src family kinases. Kidney Int 2003; 64: 404–413
   PubMedGoogle Scholar
• Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, Wary K K, Wiggins R C, Killen P, Holzman L B. Fyn binds to and phosphorylates the kidney slit diaphragm component nephrin. J Biol Chem 2003; 278: 20716–20723
   PubMedGoogle Scholar
• Wang S X, Mene P, Holthofer H. Nephrin mRNA regulation by protein kinase C. J Nephrol 2001; 14: 98–103
   PubMedGoogle Scholar
• Liu X L, Kilpeläinen P, Hellman U, Sun Y, Wartiovaara J, Morgunova E, Pikkarainen T, Yan K, Jonsson A P, Tryggvason K. Characterization of the interactions of the nephrin intracellular domain. Evidence that the scaffolding protein IQGAP1 associates with nephrin. FEBS J 2005; 272: 228–243
   PubMedGoogle Scholar
• Meier M, Menne J, Park J K, Holtz M, Gueler F, Kirsch T, Schiffer M, Mengel M, Lindschau C, Leitges M, Haller H. Deletion of protein kinase C-ε signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol 2007; 18: 1190–1198
   PubMed Web of Science ®Google Scholar
• Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman L B. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006; 116: 1346–1359
   PubMed Web of Science ®Google Scholar
• Yu C C, Yen T S, Lowell C A, DeFranco A L. Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr Biol 2001; 11: 34–38
   PubMed Web of Science ®Google Scholar
• Huber T B, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem M A, Walz G, Benzing T. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 2003; 12: 3397–3405
   PubMed Web of Science ®Google Scholar
• Li H, Lemay S, Aoudjit L, Kawachi H, Takano T. Src-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin. J Am Soc Nephrol 2004; 15: 3006–3015
   PubMedGoogle Scholar
• Quack I, Rump L C, Gerke P, Walther I, Vinke T, Vonend O, Grunwald T, Sellin L. β -arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity. Proc Natl Acad Sci USA 2006; 103: 14110–14115
   PubMedGoogle Scholar
• Huber T B, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha R L, Borner C, Pavenstadt H, Shaw A S, Walz G, Benzing T. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003; 23: 4917–4928
   PubMed Web of Science ®Google Scholar
• Foster R R, Saleem M A, Mathieson P W, Bates D O, Harper S J. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005; 288: F48–F57
   PubMed Web of Science ®Google Scholar
• Kim Y H, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60: 957–968
   PubMed Web of Science ®Google Scholar
• Tryggvason K, Pikkarainen T, Patrakka J. Nck links nephrin to actin in kidney podocytes. Cell 2006; 125: 221–224
   PubMed Web of Science ®Google Scholar
• Buday L, Wunderlich L, Tamás P. The Nck family of adapter proteins: regulators of actin cytoskeleton. Cell Signal 2002; 14: 723–731
   PubMedGoogle Scholar
• Jones N, Blasutig I M, Eremina V, Ruston J M, Bladt F, Li H, Huang H, Larose L, Li S S, Takano T, Quaggin S E, Pawson T. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006; 440: 818–823
   PubMed Web of Science ®Google Scholar
• Huber T B, Schmidts M, Gerke P, Schermer B, Zahn A, Hartleben B, Sellin L, Walz G, Benzing T. The carboxyl terminus of Neph family members binds to the PDZ domain protein zonula occludens-1. J Biol Chem 2003; 278: 13417–13421
   PubMed Web of Science ®Google Scholar
• Lehtonen S, Lehtonen E, Kudlicka K, Holthofer H, Farquhar M G. Nephrin forms a complex with adherens junction proteins and CASK in podocytes and in Madin-Darby canine kidney cells expressing nephrin. Am J Pathol 2004; 165: 923–936
   PubMedGoogle Scholar
• Lehtonen S, Ryan J J, Kudlicka K, Iino N, Zhou H, Farquhar M G. Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrin, and alpha-actinin are components of the nephrin multiprotein complex. Proc Natl Acad Sci USA 2005; 102: 9814–9819
   PubMed Web of Science ®Google Scholar
• Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420: 629–635
   PubMed Web of Science ®Google Scholar
• Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K. IQGAP1: a key regulator of adhesion and migration. J Cell Sci 2005; 118: 2085–2092
   PubMedGoogle Scholar
• Ho Y D, Joyal J L, Li Z, Sacks D B. IQGAP1 integrates Ca2+/calmodulin and Cdc42 signaling. J Biol Chem 1999; 274: 464–470
   PubMedGoogle Scholar
• Li S, Wang Q, Chakladar A, Bronson R T, Bernards A. Gastric hyperplasia in mice lacking the putative Cdc42 effector IQGAP1. Mol Cell Biol 2000; 20: 697–701
   PubMedGoogle Scholar
• Hirabayashi S, Mori H, Kansaku A, Kurihara H, Sakai T, Shimizu F, Kawachi H, Hata Y. MAGI-1 is a component of the glomerular slit diaphragm that is tightly associated with nephrin. Lab Invest 2005; 85: 1528–1543
   PubMed Web of Science ®Google Scholar
• Inoue T, Yaoita E, Kurihara H, Shimizu F, Sakai T, Kobayashi T, Ohshiro K, Kawachi H, Okada H, Suzuki H, Kihara I, Yamamoto T. FAT is a component of glomerular slit diaphragms. Kidney Int 2001; 59: 1003–1012
   PubMed Web of Science ®Google Scholar
• Moeller M J, Soofi A, Braun G S, Li X, Watzl C, Kriz W, Holzman L B. Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J 2004; 23: 3769–3779
   PubMed Web of Science ®Google Scholar
• Tanoue T, Takeichi M. New insights into Fat cadherins. J Cell Sci 2005; 118: 2347–2353
   PubMed Web of Science ®Google Scholar
• Ciani L, Patel A, Allen N D, French-Constant C. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 2003; 23: 3575–3582
   PubMed Web of Science ®Google Scholar
• Sun Y P, Björklund M, Koivunen R. Screening of a phage library with human nephrin reveals MEGF1/Fat2 as a novel component of the podocyte slit diaphragm. J Am Soc Nephrol 2005; 16: 108A, abstract
   Google Scholar
• Quaggin S E. Transcriptional regulation of podocyte specification and differentiation. Microsc Res Tech 2002; 57: 208–211
   PubMedGoogle Scholar
• Wagner K D, Wagner N, Schedi A. The complex life of WT1. J Cell Sci 2003; 116: 1653–1658
   PubMed Web of Science ®Google Scholar
• Yang Y, Jeanpierre C, Dressler G R, Lacoste M, Niaudet P, Gubler M C. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 1999; 154: 181–192
   PubMedGoogle Scholar
• Ohtaka A, Ootaka T, Sato H, Soma J, Sato T, Saito T, Ito S. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis. Am J Kidney Dis 2002; 39: 475–485
   PubMedGoogle Scholar
• Shankland S J, Eitner F, Hudkins K L, Goodpaster T, D'Agati V, Alpers C E. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000; 58: 674–683
   PubMed Web of Science ®Google Scholar
• Shankland S J, Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000; 278: F515–F529
   PubMed Web of Science ®Google Scholar
• Barbaux S, Niaudet P, Gubler M C, Grunfeld J P, Jaubert F, Kuttenn F, Fekete C N, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997; 17: 467–470
   PubMed Web of Science ®Google Scholar
• Viney R L, Morrison A A, van den Heuvel L P, Ni L, Mathieson P W, Saleem M A, Ladomery M R. A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1. Proteomics 2007; 7: 804–815
   PubMed Web of Science ®Google Scholar
• Dreyer S D, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W, Johnson R L, Lee B. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998; 19: 47–50
   PubMed Web of Science ®Google Scholar
• Rohr C, Prestel J, Heidet L, Hosser H, Kriz W, Johnson R L, Antignac C, Witzgall R. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 2002; 109: 1073–1082
   PubMedGoogle Scholar
• Suleiman H, Heudobler D, Raschta A S, Zhao Y, Zhao Q, Hertting I, Vitzthum H, Moeller M J, Holzman L B, Rachel R, Johnson R, Westphal H, Rascie A, Witzgall R. The podocyte-specific inactivation of Lmx1b, Ldb1 and E2a yields new insight into a transcriptional network in podocytes. Dev Biol 2007; 304: 701–712
   PubMedGoogle Scholar
• Quaggin S E, Schwartz L, Cui S, Igarashi P, Deimling J, Post M, Rossant J. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999; 126: 5771–5783
   PubMed Web of Science ®Google Scholar
• Sadl V, Jin F, Yu J, Cui S, Holmyard D, Quaggin S, Barsh G, Cordes S. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev Biol 2002; 249: 16–29
   PubMedGoogle Scholar
• Liu G, Clement L C, Kanwar Y S, Avila-Casado C, Chugh S S. ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome. J Biol Chem 2006; 281: 39681–39692
   PubMedGoogle Scholar
• Di Duca M, Oleggini R, Sanna-Cherchi S, Pasquali L, Di Donato A, Parodi S, Bertelli R, Caridi G, Frasca G, Cerullo G, Amoroso A, Schena F P, Scolari F, Ghiggeri G M. European IgA Nephropathy Consortium. Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal disease. Kidney Int 2006; 70: 1332–1341
   PubMedGoogle Scholar
• Corre S, Galibert M D. Upstream stimulating factors: highly versatile stress-responsive transcription factors. Pigment Cell Res 2005; 18: 337–348
   PubMedGoogle Scholar
• Ross M D, Martinka S, Mukherjee A, Sedor J R, Vinson C, Bruggeman L A. Math6 expression during kidney development and altered expression in a mouse model of glomerulosclerosis. Dev Dyn 2006; 235: 3102–3109
   PubMedGoogle Scholar
• Takemoto M, He L, Norlin J, Patrakka J, Xiao Z, Petrova T, Bondjers C, Asp J, Wallgard E, Sun Y, Samuelsson T, Mostad P, Lundin S, Miura C, Sado Y, Alitalo K, Quaggin S E, Tryggvason K, Betsholtz C. Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO J 2006; 25: 1160–1174
   PubMed Web of Science ®Google Scholar
• Regele H M, Filipovic E, Langer B, Poczewski H, Kraxberger I, Bittner R E, Kerjaschki D. Glomerular expression of dystroglycans is reduced in minimal change nephrosis, but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 2000; 11: 403–412
   PubMedGoogle Scholar
• Raats C J, van den Born J, Bakker M A, Oppers-Walgreen B, Pisa B J, Dijkman H B, Assmann K J, Berden J H. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol 2000; 156: 1749–1765
   PubMedGoogle Scholar
• Tisi D, Talts J F, Timpl R, Honenester E. Structure of the C-terminal laminin G-like domain pair of the laminin α 2 chain harbouring binding sites for α -dystroglycan and heparin. EMBO J 2000; 19: 1432–1440
   PubMedGoogle Scholar
• Williamson R A, Henry M D, Daniels K J, Hrstka R F, Lee J C, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell K P. Dystroglycan is essential for early embryonic development: disruption of Reicherts membrane in Dag1-null mice. Hum Mol Genet 1997; 6: 831–841
   PubMed Web of Science ®Google Scholar
• Good K S, O'Brien K, Schulman G, Kerjaschki D, Fogo A B. Unexplained nephrotic-range proteinuria in a 38-year old man: a case of “no change disease.”. Am J Kidney Dis 2004; 43: 933–938
   PubMedGoogle Scholar
• Kretzler M, Teixeira V P, Unschuld P G, Cohen C D, Wanke R, Edenhofer I, Mundel P, Schlondorff D, Holthofer H. Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J 2001; 15: 1843–1845
   PubMed Web of Science ®Google Scholar
• Adler S, Chen X. Anti-Fx1A antibody recognizes a β 1-integrin on glomerular epithelial cells and inhibits adhesion and growth. Am J Physiol 1992; 262: F770–F776
   PubMedGoogle Scholar
• Kreidberg J A, Donovan M J, Goldstein S L, Rennke H, Shepherd K, Jones R C, Jaenisch R. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 1996; 122: 3537–3547
   PubMed Web of Science ®Google Scholar
• Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001; 155: 505–510
   PubMed Web of Science ®Google Scholar
• Jung K Y, Chen K, Kretzler M, Wu C. TGF-β 1 regulates the PINCH-1-integrin-linked kinase-α -parvin complex in glomerular cells. J Am Soc Nephrol 2007; 18: 66–73
   PubMedGoogle Scholar
• Novak A, Hsu S C, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA 1998; 95: 4374–4379
   PubMed Web of Science ®Google Scholar
• El-Aouni C, Herbach N, Blattner S M, Henger A, Rastaldi M, Jarad G, Miner J H, Moeller M J, St-Arnaud R, Dedhar S, Holzman L B, Wanke R, Kretzler M. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J Am Soc Nephrol 2006; 17: 1334–1344
   PubMed Web of Science ®Google Scholar
• Dai C, Stolz D B, Bastacky S I, St.-Arnaud R, Wu C, Dedhar S, Liu Y. Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 2006; 17: 2164–2175
   PubMed Web of Science ®Google Scholar
• Whiteside C I, Cameron R, Munk S, Levy J. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis. Am J Pathol 1993; 142: 1641–1653
   PubMedGoogle Scholar
• Bariety J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998; 53: 918–925
   PubMed Web of Science ®Google Scholar
• Vogelmann S U, Nelson W J, Myers B D, Lemley K V. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285: F40–F48
   PubMed Web of Science ®Google Scholar
• Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 2002; 57: 247–253
   PubMed Web of Science ®Google Scholar
• Chen H C, Appeddu P A, Parsons J T, Hildebrand J D, Schaller M D, Guan J L. Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem 1995; 270: 16995–16999
   PubMed Web of Science ®Google Scholar
• Schrijvers B F, Flyvbjerg A, De Virese A S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004; 65: 2003–2017
   PubMed Web of Science ®Google Scholar
• Datta K, Li J, Karumanchi S A, Wang E, Rondeau E, Mukhopadhyay D. Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes. Kidney Int 2004; 66: 1471–1478
   PubMedGoogle Scholar
• Freeburg P B, Robert B, St. John P L, Abrahamson D R. Podocyte expression by hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development. J Am Soc Nephrol 2003; 14: 927–938
   PubMed Web of Science ®Google Scholar
• Satchell S C, Harper S J, Tooke J E, Kerjaschki D, Saleem M A, Mathieson P W. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 2002; 13: 544–550
   PubMed Web of Science ®Google Scholar
• Kang D H, Johnson R J. Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 2003; 12: 43–49
   PubMedGoogle Scholar
• Shulman K, Rosen S, Tognazzi K, Manseau E J, Brown L F. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 1996; 7: 661–666
   PubMed Web of Science ®Google Scholar
• Liang X B, Ma L J, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo A B. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J Am Soc Nephrol 2006; 17: 1886–1895
   PubMedGoogle Scholar
• Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner J H, Quaggin S E. Vascular endothelial growth factor A signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006; 17: 724–735
   PubMed Web of Science ®Google Scholar
• Noris M, Perico N, Remuzzi G. Mechanisms of disease: preeclampsia. Nat Clin Pract Nephrol 2005; 1: 98–114
   PubMedGoogle Scholar
• Maynard S, Min J Y, Merchan J, Lim K H, Li J, Mondal S, Libermann T A, Morgan J P, Sellke F W, Stillman I E, Epstein F H, Sukhatme V P, Karumanchi S A. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649–658
   PubMed Web of Science ®Google Scholar
• Lindheimer M D. Unraveling the mysteries of preeclampsia. Am J Obstet Gynecol 2005; 193: 3–4
   PubMedGoogle Scholar
• Bdolah Y, Palomaki G E, Yaron Y, Bdolah-Abram T, Goldman M, Levine R J, Sachs B P, Haddow J E, Karumanchi S A. Circulating angiogenic proteins in trisomy 13. Am J Obstet Gynecol 2006; 194: 239–245
   PubMed Web of Science ®Google Scholar
• Yang J C, Haworth L, Sherry R M, Hwu P, Schwartzentruber D J, Topalian S L, Steinberg S M, Chen H X, Rosenberg S A. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003; 349: 427–434
   PubMed Web of Science ®Google Scholar
• Zhu X, Wu S, Dahut W, Parikh C R. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis 2007; 49: 186–193
   PubMed Web of Science ®Google Scholar
• Baelde H J, Eikmans M, Lappin D W, Doran P P, Hohenadel D, Brinkkoetter P T, van der Woude F J, Waldherr R, Rabelink T J, de Heer E. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int 2007; 71: 637–645
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Gao S, Chen J, Saito K, Miyawaki K, Li C Y, Pan L, Saito S, Terashita T, Matsuda S. Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons. Anat Sci Int 2004; 79: 1–10
   PubMedGoogle Scholar
• Rastaldi M P, Armelloni S, Berra S, Calvaresi N, Corbelli A, Giardino L A, Li M, Wang G O, Fornasieri A, Villa A, Heikkila E, Soliymani R, Boucherot A, Cohen C D, Kretzler M, Nitsche A, Ripamonti M, Malgaroli A, Pesaresi M, Forloni G L, Schlondorff D, Holthofer H, D'Amico G. Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J 2006; 20: 976–978
   PubMedGoogle Scholar
• Beltcheva O, Kontusaari S, Fetissov S, Putaala H, Kilpelainen P, Hokfelt T, Tryggvason K. Alternatively used promoters and distinct elements direct tissue-specific expression of nephrin. J Am Soc Nephrol 2003; 14: 352–358
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Reiser J, Kriz W, Kuriyama R, Mundel P. Non-uniform microtubular polarity, established by CHO1/MKLP1 motor protein, is necessary for process formation of podocytes. J Cell Biol 1998; 143: 1961–1970
   PubMedGoogle Scholar
• Simons M, Saffrich R, Reiser J, Mundel P. Directed membrane transport is involved in process formation in cultured podocytes. J Am Soc Nephrol 1999; 10: 1633–1639
   PubMedGoogle Scholar
• Rastaldi M P, Armelloni S, Berra S, Li M, Pesaresi M, Poczewski H, Langer B, Kerjaschki D, Henger A, Blattner S M, Kretzler M, Wanke R, D'Amico G. Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector Rabphilin-3a. Am J Pathol 2003; 163: 889–899
   PubMedGoogle Scholar
• Cormont M, Meton I, Mari M, Monzo P, Keslair F, Gaskin C, McGraw T E, Le Marchand-Brustel Y. CD2AP/CMS regulates endosome morphology and traffic to the degradative pathway through its interaction with Rab4 and c-Cbl. Traffic 2003; 4: 97–112
   PubMed Web of Science ®Google Scholar
• Peitsch W K, Hofmann I, Endlich N, Pratzel S, Kuhn C, Spring H, Grone H J, Kriz W, Franke W W. Cell biological and biochemical characterization of drebrin complexes in mesangial cells and podocytes of renal glomeruli. J Am Soc Nephrol 2003; 14: 1452–1463
   PubMedGoogle Scholar
• Gloy J, Reitinger S, Fischer K G, Schreiber R, Boucherot A, Kunzelmann K, Mundel P, Pavenstadt H. Amino acid transporter in podocytes. Am J Physiol Renal Physiol 2000; 278: F999–F1005
   PubMedGoogle Scholar
• Thomas P E, Wharram B L, Goyal M, Wiggins J E, Holzman L B, Wiggins R C. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. J Biol Chem 1994; 269: 19953–19962
   PubMedGoogle Scholar
• Yang D H, Goyal M, Sharif K, Kershaw D, Thomas P, Dysko R, Wiggins R. Glomerular epithelial protein 1 and podocalyxin-like protein 1 in inflammatory glomerular disease (crescentic nephritis) in rabbit and man. Lab Invest 1996; 74: 571–584
   PubMedGoogle Scholar
• Wharram B L, Goyal M, Gillespie P J, Wiggins J E, Kershaw D G, Holzman L B, Dysko R C, Saunders T L, Samuelson L C, Wiggins R C. Altered podocyte structure in GLEPP1 (Pt-pro)-deficient mice associated with hypertension and low glomerular filtration rate. J Clin Invest 2000; 106: 1281–1290
   PubMed Web of Science ®Google Scholar
• Asanuma K, Kim K, Oh J, Giardino L, Chabanis S, Faul C, Reiser J, Mundel P. Synaptopodin regulates the actin-bundling activity of α -actinin in an isoform-specific manner. J Clin Invest 2005; 115: 1188–1198
   PubMed Web of Science ®Google Scholar
• Deller T, Korte M, Chabanis S, Drakew A, Schwegler H, Stefani G G, Zuniga A, Schwarz K, Bonhoeffer T, Zeller R, Frotscher M, Mundel P. Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity. Proc Natl Acad Sci USA 2003; 100: 10494–10499
   PubMed Web of Science ®Google Scholar
• Kemeny E, Durmuller U, Nickeleit V, Gudat F, Mihatsch M J. Distribution of podocyte protein (44 KD) in different types of glomerular diseases. Virchows Arch 1997; 431: 425–430
   PubMedGoogle Scholar
• Paul M D, Fernandez D, Pryse-Phillips W, Gault M H. Charcot-Marie-Tooth disease and nephropathy in a mother and daughter with a review of the literature. Nephron 1990; 54: 80–85
   PubMedGoogle Scholar
• Plaisier E, Mougenot B, Verpont M C, Jouanneau C, Archelos J J, Martini R, Kerjaschki D, Ronco P. Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells. J Am Soc Nephrol 2005; 16: 3350–3364
   PubMedGoogle Scholar
• Gross O, Beirowski B, Harvey S J, McFadden C, Chen D, Tam S, Thorner P S, Smyth N, Addicks K, Bloch W, Ninomiya Y, Sado Y, Weber M, Vogel W F. DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney Int 2004; 66: 102–111
   PubMedGoogle Scholar
• Miyauchi N, Saito A, Karasawa T, Harita Y, Suzuki K, Koike H, Han G D, Shimizu F, Kawachi H. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli. J Am Soc Nephrol 2006; 17: 2748–2759
   PubMedGoogle Scholar
• Guan F, Villegas G, Teichman J, Mundel P, Tufro A. Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival. Kidney Int 2006; 69: 1564–1569
   PubMed Web of Science ®Google Scholar
• Tamagnone L, Comoglio P M. To move or not to move? Semaphorin signalling in cell migration. EMBO Rep 2004; 5: 356–361
   PubMed Web of Science ®Google Scholar
• Kriz W. TRPC6—a new podocyte gene involved in focal segmental glomerulosclerosis. Trends Mol Med 2005; 11: 527–530
   PubMedGoogle Scholar
• Koziell A, Grech V, Hussain S, Lee G, Lenkkeri U, Tryggvason K, Scambler P. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional interrelationship in glomerular filtration. Hum Mol Genet 2002; 11: 379–388
   PubMed Web of Science ®Google Scholar
• Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri G M. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12: 2742–2746
   PubMed Web of Science ®Google Scholar
• Karle S M, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002; 13: 388–393
   PubMed Web of Science ®Google Scholar
• Tsukaguchi H, Yager H, Dawborn J, Jost L, Cohlmia J, Abreu P F, Pereira A B, Pollak M R. A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. J Am Soc Nephrol 2000; 11: 1674–1680
   PubMed Web of Science ®Google Scholar
• Weber S, Gribouval O, Esquivel E L, Moriniere V, Tete M J, Ledendre C, Niaudet P, Antignac C. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66: 571–579
   PubMed Web of Science ®Google Scholar
• Caridi G, Perfumo F, Ghiggeri G M. NPHS2 (podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 2005; 57: 54R–61R
   PubMedGoogle Scholar
• He N, Zahirieh A, Mei Y, Lee B, Senthilnathan S, Wong B, Mucha B, Hildebrandt F, Cole D E, Cattran D, Pei Y. Recessive NPHS2 (podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2007; 2: 31–37
   PubMed Web of Science ®Google Scholar
• Ruf R G, Lichtenberger A, Karle S M, Haas J P, Anacleto F E, Schultheiss M, Zalewski I, Imm A, Ruf E M, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004; 15: 722–732
   PubMed Web of Science ®Google Scholar
• Vincenti F, Ghiggeri G M. New insights into the pathogenesis and therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005; 5: 1179–1185
   PubMed Web of Science ®Google Scholar
• Becker-Cohen R, Bruschi M, Rinat C, Feinstein S, Zennaro C, Ghiggeri C M, Frishberg Y. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant 2007; 7: 256–260
   PubMedGoogle Scholar
• Frishberg Y, Feinstein S, Rinat C, Becker-Cohen R, Lerer I, Raas-Rothschild A, Ferber B, Nir A. The heart of children with steroid-resistant nephrotic syndrome: is it all podocin?. J Am Soc Nephrol 2006; 17: 227–231
   PubMedGoogle Scholar
• Blum S, Nakhoul F, Khankin E, Abassi Z. Renal slit diaphragm—the open zipper and the failing heart. Isr Med Assoc J 2007; 9: 107–111
   PubMedGoogle Scholar
• Pereira A C, Pereira A B, Mota G F, Cunha R S, Herkenhoff F L, Pollak M R, Mill J G, Krieger J E. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004; 65: 1026–1030
   PubMed Web of Science ®Google Scholar
• Franceschini N, North K E, Kopp J B, McKenzie L, Winkler C. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med 2006; 8: 63–75
   PubMed Web of Science ®Google Scholar
• Kaplan J M, Kim S H, North K N, Rennke H, Correia L A, Tong H Q, Mathis B J, Rodriguez-Perez J C, Allen P G, Beggs A H, Pollak M R. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251–256
   PubMed Web of Science ®Google Scholar
• Kos C H, Le T C, Sinha S, Henderson J M, Kim S H, Sugimoto H, Kalluri R, Gerszten R E, Pollak M R. Mice deficient in α -actinin-4 have severe glomerular disease. J Clin Invest 2003; 111: 1683–1690
   PubMed Web of Science ®Google Scholar
• Michaud J L, Chaisson K M, Parks R J, Kennedy C R. FSGS-associated α -actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes. Kidney Int 2006; 70: 1054–1061
   PubMedGoogle Scholar
• Yao J, Le T C, Kos C H, Henderson J M, Allen P G, Denker B M, Pollak M R. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PloS Biol 2004; 2: e167
   PubMedGoogle Scholar
• Winn M, Conlon P, Lynn K, Howell D N, Slotterbeck B D, Smith A H, Graham F L, Bembe M, Quarles L D, Pericak-Vance M A, Vance J M. Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 1999; 58: 113–120
   PubMedGoogle Scholar
• Möller C C, Wei C, Altintas M M, Li J, Greka A, Ohse T, Pippin J W, Rastaldi M P, Wawersik S, Schiavi S, Henger A, Kretzler M, Shankland S J, Reiser J. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 2007; 18: 29–36
   PubMed Web of Science ®Google Scholar
• Kim J M, Wu H, Green G, Winkler C A, Kopp J B, Miner J H, Unanue E R, Shaw A S. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003; 300: 1298–1300
   PubMed Web of Science ®Google Scholar
• Huber T B, Kwoh C, Wu H, Asanuma K, Godel M, Hartleben B, Blumer K J, Miner J H, Mundel P, Shaw A S. Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest 2006; 116: 1337–1345
   PubMed Web of Science ®Google Scholar
• Hinkes B, Wiggins R C, Gbadegesin R, Vlangos C N, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins B E, Ashraf S, Becker C, Hennies H C, Goyel M, Wharram B L, Schachter A D, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkalolu A, Cleper R, Base-Vanagaite L, Pohl M, Griebel M, Tsygin A N, Soylu A, Muller D, Sorli C S, Bunney T D, Katan M, Liu J, Attanasio M, O'Toole J F, Hasselbacher K, Mucha B, Otto E A, Airik R, Kispert A, Kelley G G, Smrcka A V, Gudermann T, Holzmann L B, Nurnberg P, Hildebrandt F. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Gen 2006; 38: 1397–1405
   PubMed Web of Science ®Google Scholar
• Bunney T D, Katan M. Phospholipase C epsilon: linking second messengers and small GTPases. Trends Cell Biol 2006; 16: 640–648
   PubMed Web of Science ®Google Scholar
• Wang H, Oestreich E A, Maekawa N, Bullard T A, Vikstrom K L, Dirksen R T, Kelley G G, Blaxall B C, Smrcka A V. Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy. Circ Res 2005; 97: 1305–1313
   PubMed Web of Science ®Google Scholar
• Bongers E M, Gubler M C, Knoers N V. Nail-patella syndrome: overview on clinical and molecular findings. Pediatr Nephrol 2002; 17: 703–712
   PubMed Web of Science ®Google Scholar
• Wuhl E, Kogan J, Zurowska A, Matejas V, Vandevoorde R G, Aigner T, Wendler O, Lesniwska I, Bouvier R, Reis A, Weis J, Cochat P, Zenkter M. Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am J Med Genet 2007; 15: 311–319
   Google Scholar
• Arfeen S, Rosborough D, Luger A M, Nolph K D. Familial unilateral renal agenesis and focal and segmental glomerulosclerosis. Am J Kidney Dis 1993; 21: 663–668
   PubMedGoogle Scholar
• Pelletier J, Bruening W, Kashtan C E, Mauer S M, Manivel J C, Striegel J E, Houghton D C, Junien C, Habib R, Fouser L. Germline mutations in the Wilms tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991; 67: 437–447
   PubMed Web of Science ®Google Scholar
• Orloff M S, Iyengar S K, Winkler C A, Dart R A, Ahuja T S, Mokrzycki M, Briggs W A, Korbet S M, Kimmel P L, Simon E E, Trachtman H, Vlahov D, Michel D M, Berns J S, Smith M C, Schelling J R, Sedor J R, Goddard K A, Kopp J B. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics 2005; 21: 212–221
   PubMed Web of Science ®Google Scholar
• Kambham N, Tanji N, Seigle R L, Markowitz G S, Pulkkinen L, Uitto J, D'Agati V D. Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa. Am J Kidney Dis 2000; 36: 190–196
   PubMedGoogle Scholar
• Comper W D, Glasgow E F. Charge selectivity in kidney ultrafiltration. Kidney Int 1995; 47: 1242–1251
   PubMedGoogle Scholar
• Goode N P, Shires M, Davison A M. The glomerular basement membrane charge-selectivity barrier: an oversimplified concept?. Nephrol Dial Transplant 1996; 11: 1714–1716
   PubMed Web of Science ®Google Scholar
• Bridges C R, Myers B D, Brenner B M, Deen W M. Glomerular charge alterations in human minimal change nephropathy. Kidney Int 1982; 22: 677–684
   PubMedGoogle Scholar
• Shemesh O, Ross J C, Deen W M, Grant G W, Myers B D. Nature of the glomerular capillary injury in human membranous glomerulopathy. J Clin Invest 1986; 77: 868–877
   PubMedGoogle Scholar
• Myers B D, Guasch A. Mechanisms of proteinuria in nephrotic humans. Pediatr Nephrol 1994; 8: 107–112
   PubMedGoogle Scholar
• Lahdenkari A T, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, Kestila M, Koskimies O, Jalanko H. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 2004; 15: 2611–2618
   PubMed Web of Science ®Google Scholar
• Shah S, Baliga R, Rajapukar M, Fonseca V A. Oxidants in chronic kidney disease. J Am Soc Nephrol 2007; 18: 16–28
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Yamagata K, Capaldi R A, Koyama A. Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis. Kidney Int 2006; 69: 1146–1152
   PubMedGoogle Scholar
• Ricardo S D, Bertram J F, Ryan G B. Reactive oxygen species in puromycin aminonucleoside nephrosis: in vitro studies. Kidney Int 1994; 45: 1057–1069
   PubMed Web of Science ®Google Scholar
• Ricardo S D, Bertram J F, Ryan G B. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. J Am Soc Nephrol 1994; 4: 1974–1986
   PubMed Web of Science ®Google Scholar
• Zima T, Tesar V, Crkovska J, Stejskalova A, Platenik J, Teminova J, Nemecek K, Janebova M, Stipek S. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats. Nephrol Dial Transplant 1998; 13: 1975–1979
   PubMed Web of Science ®Google Scholar
• Koshikawa M, Mukoyama M, Mori K, Saganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugiwara A, Nakao K. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 2005; 16: 2690–2701
   PubMed Web of Science ®Google Scholar
• Luimula P, Ahola H, Wang S X, Solin M L, Aaltonen P, Tikkanen I, Kerjaschki D, Holthofer H. Nephrin in experimental glomerular disease. Kidney Int 2000; 58: 1461–1468
   PubMed Web of Science ®Google Scholar
• Shaloub R J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2: 556
   PubMed Web of Science ®Google Scholar
• Savin V J, Sharma R, Sharma M, McCarthy E T, Swan S K, Ellis E, Lovell H, Warady B, Gunwar S, Chonko A M, Artero M, Vincenti F. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878–883
   PubMed Web of Science ®Google Scholar
• Garin E H. Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2000; 14: 872–878
   PubMed Web of Science ®Google Scholar
• Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou J P. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 7–14
   PubMed Web of Science ®Google Scholar
• Sharma M, Sharma R, McCarthy E T, Savin V J. “The FSGS factor”: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999; 10: 552–561
   PubMed Web of Science ®Google Scholar
• Trachtman H, Futterweit S, Singhal P C, Franki N, Sharma M, Sharma R, Savin V. Circulating factor in patients with recurrent focal segmental glomerulosclerosis postrenal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells. J Invest Med 1999; 47: 114–120
   PubMedGoogle Scholar
• Koyama A, Fukisaki M, Kobayashi M, Igarashi M, Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991; 40: 453–460
   PubMed Web of Science ®Google Scholar
• Sahali D, Pawlak A, Valanciuté A, Grimbert P, Lang P, Remy P, Bensman A, Guellaen G. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 2002; 13: 1238–1247
   PubMedGoogle Scholar
• Cunard R, Kelly C J. T cells and minimal change disease. J Am Soc Nephrol 2002; 13: 1409–1411
   PubMed Web of Science ®Google Scholar
• Carraro M, Caridi G, Bruschi M, Artero M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri G M. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002; 13: 1946–1952
   PubMed Web of Science ®Google Scholar
• Cattran D, Neogi T, Sharma R, McCarthy E T, Savin V J. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 2003; 14: 448–453
   PubMed Web of Science ®Google Scholar
• Sharma R, Sharma M, McCarthy E T, Ge X L, Savin V J. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 2000; 58: 1973–1979
   PubMed Web of Science ®Google Scholar
• Candiano G, Musante L, Carraro M, Faccini L, Campanacci L, Zennaro C, Artero M, Ginevri F, Perfumo F, Gusmano R, Ghiggeri G M. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12: 143–150
   PubMedGoogle Scholar
• Ghiggeri G M, Artero M, Carraro M, Perfumo F. Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor. Nephrol Dial Transplant 2001; 16: 882–885
   PubMed Web of Science ®Google Scholar
• Musante L, Candiano G, Bruschi M, Zennaro C, Carrato M, Artero M, Giuffrida M G, Conti A, Santucci A, Ghiggeri G M. Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics 2002; 2: 197–205
   PubMedGoogle Scholar
• Ghiggeri G M, Bruschi M, Candiano G, Rastaldi M P, Scolari F, Passerini P, Musante L, Pertica N, Caridi G, Ferrario F, Perfumo F, Ponticelli C. Depletion of clusterin in renal diseases causing nephrotic syndrome. Kidney Int 2002; 62: 2184–2194
   PubMedGoogle Scholar
• Carraro M, Zennaro C, Candiano G, Musante L, Bruschi M, Ghiggeri G M, Artero M, Faccini L. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome. Nephrol Dial Transplant 2003; 18: 689–693
   PubMedGoogle Scholar
• Sharma M, Sharma R, McCarthy E T, Savin V J. The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects. Exp Biol Med 2004; 229: 85–98
   Web of Science ®Google Scholar
• Doublier S, Musante L, Lupia E, Candiano G, Spatola T, Caridi G, Zennaro C, Carraro M, Ghiggeri G M, Camussi G. Direct effect of plasma permeability factors from patients with idiopathic FSGS on nephrin and podocin expression in human podocytes. Int J Mol Med 2005; 16: 49–58
   PubMedGoogle Scholar
• Marszal J, Saleem M A. The bioactivity of plasma factors in focal segmental glomerulosclerosis. Nephron Exp Nephrol 2006; 104: e1–e5
   PubMedGoogle Scholar
• Furness P N, Hall L L, Shaw J A, Pringle J H. Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant 1999; 14: 1234–1237
   PubMed Web of Science ®Google Scholar
• Patrakka J, Ruotsalainen V, Ketola I, Holmberg C, Heikinheimo M, Tryggvason K, Jalanko H. Expression of nephrin in pediatric kidney diseases. J Am Soc Nephrol 2001; 12: 289–296
   PubMedGoogle Scholar
• Koop K, Eikmans M, Baelde H J, Kawachi H, de Heer E, Leendert C P, Bruijn J A. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063–2071
   PubMed Web of Science ®Google Scholar
• Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L. Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol 2006; 21: 1666–1675
   PubMedGoogle Scholar
• Schmid H, Henger A, Cohen C D, Frach K, Grone H J, Schlondorff D, Kretzler M. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958–2966
   PubMed Web of Science ®Google Scholar
• Szeto C C, Lai K B, Chow K M, Szeto C Y, Yip T W, Woo K S, Li P K, Lai F M. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta 2005; 361: 182–190
   PubMed Web of Science ®Google Scholar
• Sharif K, Goyal M, Kershaw D, Kunkel R, Wiggins R. Podocyte phenotypes as defined by expression and distribution of GLEPP-1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome. Exp Nephrol 1998; 6: 234–244
   PubMedGoogle Scholar
• Devarajan P, Spitzer A. Towards biological characterization of focal segmental glomerulosclerosis. Am J Kidney Dis 2002; 39: 625–636
   PubMedGoogle Scholar
• Tanawattanacharoen S, Falk R, Jennette C, Kopp J B. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 2000; 35: 1166–1174
   PubMed Web of Science ®Google Scholar
• Ingulli E, Tejani A. Incidence, treatment and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children: a single-center experience. Transplantation 1991; 51: 401–405
   PubMed Web of Science ®Google Scholar
• Artero M L, Sharma R, Savin V J, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574–581
   PubMed Web of Science ®Google Scholar
• Feld S M, Figueroa P, Savin V, Nast C C, Sharma R, Sharma M, Hirschberg R, Adler S G. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 1998; 32: 230–237
   PubMed Web of Science ®Google Scholar
• Srivastava T, Garola R E, Whiting J M, Alon U S. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 2001; 59: 118–125
   PubMedGoogle Scholar
• Mrowka C, Schedl A. Wilms tumor suppressor gene WT1: from structure to renal pathophysiologic features. J Am Soc Nephrol 2000; 11(Suppl 16)S106–S115
   PubMedGoogle Scholar
• Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z. Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103–111
   PubMed Web of Science ®Google Scholar
• Ortiz A. Apoptotic regulatory proteins in renal injury. Kidney Int 2000; 58: 467–485
   PubMed Web of Science ®Google Scholar
• Mayo M W, Wang C Y, Drouin S S, Madrid L V, Marshall A F, Reed J C, Weissman B E, Baldwin A S. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J 1999; 18: 3990–4003
   PubMed Web of Science ®Google Scholar
• Schiffer M, Bitzer M, Roberts I S, Kopp J B, ten Dijke P, Mundel P, Bottinger E P. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807–816
   PubMed Web of Science ®Google Scholar
• Wharram B L, Goyal M, Wiggins J E, Sanden S K, Hussain S, Filipiak W E, Saunders T L, Dysko R C, Kohno K, Hozman L B, Wiggins R C. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16: 2941–2952
   PubMed Web of Science ®Google Scholar
• Schwab K, Witte D P, Aronow B J, Devarajan P, Potter S C, Patterson L T. Microarray analysis of focal segmental glomerulosclerosis. Am J Nephrol 2004; 24: 438–447
   PubMedGoogle Scholar
• Albaqumi M, Soos T J, Barisoni L, Nelson P J. Collapsing glomerulopathy. J Am Soc Nephrol 2006; 17: 2854–2863
   PubMed Web of Science ®Google Scholar
• Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 2000; 58: 137–143
   PubMed Web of Science ®Google Scholar
• Shah S N, He C J, Klotman P. Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens 2006; 15: 450–455
   PubMedGoogle Scholar
• Husain M, D'Agati V, He J C, Klotman M E, Klotman P E. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 2005; 19: 1975–1980
   PubMed Web of Science ®Google Scholar
• Doublier S, Zennaro C, Spatola T, Lupia E, Bottelli A, Deregibus M C, Carraro M, Conaldi P G, Camussi G. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. AIDS 2007; 21: 423–432
   PubMedGoogle Scholar
• Nelson P J, Shankland S J. Therapeutics in renal disease: The road ahead for antiproliferative targets. Nephron Exp Nephrol 2006; 103: e6–e15
   PubMedGoogle Scholar
• Gherardi D, D'Agati V, Chu T H, Barnett A, Gianella-Borradori A, Gelman I H, Nelson P J. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 2004; 15: 1212–1222
   PubMedGoogle Scholar
• Soos T J, Meijer L, Nelson P J. CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases. Drug News Perspect 2006; 19: 314–317
   Google Scholar
• Vaughan M R, Pippin J, Griffin S V, Kroft R, Fleet M, Haseley L, Shankland S J. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int 2005; 68: 133–144
   PubMed Web of Science ®Google Scholar
• Hermann M, Shaw S, Kiss E, Camici G, Buhler N, Chenevard R, Luscher T F, Grone H J, Ruschitzka F. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension 2005; 45: 193–197
   PubMedGoogle Scholar
• Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois M H, Sagot Y. IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am J Pathol 2004; 164: 1253–1262
   PubMed Web of Science ®Google Scholar
• Chen H M, Liu Z H, Zeng C H, Li S J, Wang Q W, Li L S. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 2006; 48: 772–779
   PubMedGoogle Scholar
• White K E, Bilous R W, Marshall S M, El Nahas M, Remuzzi G, Piras G, De Cosmo S, Viberti G. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002; 51: 3083–3089
   PubMed Web of Science ®Google Scholar
• Kriz W, Gretz N, Lemley K V. Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int 1998; 54: 687–697
   PubMed Web of Science ®Google Scholar
• Kriz W. Podocyte is the major culprit accounting for the progression of chronic disease. Microvasc Res Tech 2002; 57: 189–195
   PubMed Web of Science ®Google Scholar
• Kambham N, Markowitz G S, Valeri A M, Lin J, D'Agati V D. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498–1509
   PubMed Web of Science ®Google Scholar
• Praga M. Obesity—a neglected culprit in renal disease. Nephrol Dial Transplant 2002; 17: 1157–1159
   PubMedGoogle Scholar
• Pagtalunan M E, Miller P L, Jumping-Eagle S, Nelson R G, Myers B D, Rennke H G, Coplon N S, Sun L, Meyer T W. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342–348
   PubMed Web of Science ®Google Scholar
• Kerjaschki D, Farquhar M G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA 1982; 79: 5557–5561
   PubMed Web of Science ®Google Scholar
• Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann J P, Bensman A, Deschenes G, Ronco P M. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053–2060
   PubMed Web of Science ®Google Scholar
• Ronco P, Debiec H. Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies. J Am Soc Nephrol 2006; 17: 1772–1774
   PubMedGoogle Scholar
• Nangaku M, Shankland S J, Couser W G. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 2005; 16: 1195–1204
   PubMed Web of Science ®Google Scholar
• Salant D J, Belok S, Madaio M P, Couser W G. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 1980; 66: 1339–1350
   PubMed Web of Science ®Google Scholar
• Baker P J, Ochi R F, Schulze M, Johnson R J, Campbell C, Couser W G. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol 1989; 135: 185–194
   PubMed Web of Science ®Google Scholar
• Matsuo S, Morita Y, Yuzawa Y, Maruyama S. Urinary membrane attack complex (MAC) is a potent predictor of poor renal outcome in proteinuric glomerular diseases. J Am Soc Nephrol 2004; 15: 328A, abstract
   Google Scholar
• Greiber S, Munzel T, Kastner S, Muller B, Schollmeyer P, Pavenstadt H. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int 1998; 53: 654–663
   PubMed Web of Science ®Google Scholar
• Takano T, Cybulsky A V, Cupples W A, Ajikobi D O, Papillon J, Aoudjit L. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis. J Pharmacol Exp Ther 2003; 305: 240–249
   PubMed Web of Science ®Google Scholar
• Minto A W, Kalluri R, Togawa M, Bergijk E C, Killen P D, Salant D J. Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy. Proc Assoc Am Physicians 1998; 110: 207–217
   PubMedGoogle Scholar
• Shankland S J, Pippin J, Pichler R H, Gordon K L, Friedman S, Gold L I, Johnson R J, Couser W G. Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy. Kidney Int 1996; 50: 116–124
   PubMed Web of Science ®Google Scholar
• Topham P S, Haydar S A, Kuphal R, Lightfoot J D, Salant D J. Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int 1999; 55: 1763–1775
   PubMedGoogle Scholar
• Moll S, Lange S, Mihatsch M J, Dragic Z, Schifferli J A, Inal J M. CRIT is expressed on podocytes in normal human kidney and upregulated in membranous nephropathy. Kidney Int 2006; 69: 1961–1968
   PubMedGoogle Scholar
• Yuan H, Takeuchi E, Taylor G A, McLaughlin M, Brown D, Salant D J. Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 2002; 13: 946–956
   PubMedGoogle Scholar
• Nakatsue T, Koike H, Han G D, Suzuki K, Miyauchi N, Yuan H, Salant D J, Gejyo F, Shimizu F, Kawachi H. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int 2005; 67: 2239–2353
   PubMed Web of Science ®Google Scholar
• Kim B K, Hong H K, Kim J H, Lee H S. Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis 2002; 40: 964–973
   PubMedGoogle Scholar
• Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer J A, Kalluri R, Remuzzi G. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 2001; 12: 941–948
   PubMed Web of Science ®Google Scholar
• Nitschke R, Henger A, Ricken S, Gloy J, Muller V, Greger R, Pavenstadt H. Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus. Kidney Int 2000; 57: 41–49
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Monaci N, Bonassi M E, Corna D, Zoja C, Mohammed E I, Remuzzi G. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive Heymann nephritis. Lab Invest 1999; 79: 1501–1510
   PubMedGoogle Scholar
• Ding G, Reddy K, Kapasi A A, Franki N, Gibbons N, Kasinath B S, Singhal P C. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002; 283: F173–F180
   PubMed Web of Science ®Google Scholar
• Nagata M, Yamaguchi Y, Komatsu Y, Ito K. Mitosis and the presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nephron 1995; 70: 68–71
   PubMed Web of Science ®Google Scholar
• Shankland S J, Pippin J, Couser W G. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney Int 1999; 56: 538–548
   PubMedGoogle Scholar
• Hara M, Yanagihara T, Kihara I. Apical cell membranes are shed into urine from injured podocytes in IgA nephropathy: proposal of hypothesis about podocyte injury. Nephrology 2004; 9: A51, abstract
   Google Scholar
• Kanno K, Kawachi H, Uchida Y, Hara M, Shimizu F, Uchiyama M. Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract 2003; 95: c91–c99
   PubMedGoogle Scholar
• Saleem M. Urine – a mirror of the (glomerular) soul?. Nephron Clin Pract 2003; 95: c75–c76
   PubMedGoogle Scholar
• Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy. Am J Nephrol 2000; 20: 373–379
   PubMedGoogle Scholar
• Gagliardini E, Benigni A, Tomasoni S, Abbate M, Kalluri R, Remuzzi G. Targeted downregulation of extracellular nephrin in human IgA nephropathy. Am J Nephrol 2003; 23: 277–286
   PubMedGoogle Scholar
• Qiu L Q, Sinniah R, Hsu S I. Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy. J Am Soc Nephrol 2004; 15: 79–90
   PubMed Web of Science ®Google Scholar
• Lemley K V, Lafayette R A, Safai M, Derby G, Blouch K, Squarer A, Myers B D. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61: 1475–1485
   PubMed Web of Science ®Google Scholar
• Han T S, Schwartz M M, Lewis E J. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 2006; 15: 71–75
   PubMed Web of Science ®Google Scholar
• Zheng L, Sinniah R, Hsu S I. In situ glomerular expression of activated NF-κ B in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch 2006; 448: 172–183
   PubMedGoogle Scholar
• Wolf G, Chen S, Ziyadeh F N. From the periphery of the glomerular capillary wall toward the center of disease. Podocyte injury comes of age in diabetic nephropathy. Diabetes 2006; 54: 1626–1634
   Google Scholar
• Coimbra T M, Janssen U, Grone H J, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 162–182
   Google Scholar
• Mifsud S A, Allen T J, Bertram J F, Hulthen U L, Kelly D J, Cooper M E, Wilkinson-Berka J L, Gilbert R E. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade. Diabetologia 2001; 44: 878–882
   PubMed Web of Science ®Google Scholar
• Han S Y, Kang Y S, Jee Y H, Han K H, Cha D R, Kang S W, Han D S. High glucose and angiotensin II increase beta 1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes. Cell Tissue Res 2006; 323: 321–332
   PubMedGoogle Scholar
• Yoo T H, Li J J, Kim J J, Jung D S, Kwak S J, Ryu D R, Choi H Y, Kim J S, Kim H J, Han S H, Lee J E, Han D S, Kang S W. Activation of the renin-angiotensin system within podocytes in diabetics. Kidney Int 2007; 71: 1019–1027
   PubMedGoogle Scholar
• Huang X R, Chen W Y, Truong L D, Lan H Y, Wang S X. Chymase is upregulated in diabetic nephropathy: implications of an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol 2003; 14: 1738–1747
   PubMed Web of Science ®Google Scholar
• Ziadeh F N. Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 2004; 15(Suppl 1)S55–S57
   PubMedGoogle Scholar
• Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts A B, Saito Y, Mori S. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 2003; 305: 1002–1007
   PubMed Web of Science ®Google Scholar
• Meyer T W, Bennett P H, Nelson R G. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 1999; 42: 1341–1344
   PubMed Web of Science ®Google Scholar
• Dalla Vestra M, Masiero A, Roiter A M, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003; 52: 1031–1035
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15: 1475–1487
   PubMed Web of Science ®Google Scholar
• Gross M L, El-Shakmak A, Szabo A, Koch A, Kuhlmann A, Munter K, Ritz E, Amann K. ACE-inhibitors, but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 2003; 46: 856–868
   PubMed Web of Science ®Google Scholar
• Kelly D J, Aaltonen P, Cox A J, Rumble J R, Langham R, Panagiotopoulos S, Jerums G, Holthofer H, Gilbert R E. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 2002; 17: 1327–1332
   PubMed Web of Science ®Google Scholar
• Davis B J, Cao Z, de Gasparo M, Kawachi H, Cooper M E, Allen T J. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin. J Hypertens 2003; 21: 209–216
   PubMed Web of Science ®Google Scholar
• Petermann A T, Pippin J, Krofft R, Blonski M, Griffin S, Durvasula R, Shankland S J. Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis. Nephron Exp Nephrol 2004; 98: e114–e123
   PubMedGoogle Scholar
• Chen H C, Chen C A, Guh J Y, Chang J M, Shin S J, Lai Y H. Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes. Life Sci 2000; 67: 2345–2353
   PubMed Web of Science ®Google Scholar
• Kitsiou P V, Tzinia A K, Stetler-Stevenson W G, Michael A F, Fan W W, Zhou B, Tsilibary E C. Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol 2003; 284: F671–F679
   PubMed Web of Science ®Google Scholar
• Kagami S, Border W A, Ruoslahti E, Noble N A. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest 1993; 69: 68–76
   PubMed Web of Science ®Google Scholar
• Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy. FASEB J 2005; 19: 127–129
   PubMedGoogle Scholar
• Khoshnoodi J, Sigmundsson K, Ofverstedt L G, Skoglund U, Obrink B, Wartiovaara J, Tryggvason K. Nephrin promotes cell-cell adhesion through homophilic interactions. Am J Pathol 2003; 163: 2337–2346
   PubMedGoogle Scholar
• De Vriese A S, Tilton R G, Elger M, Stephan C C, Kriz W, Lameire N H. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001; 12: 993–1000
   PubMed Web of Science ®Google Scholar
• Cooper M E, Vranes D, Youssef S, Stacker S A, Cox A J, Rizkalla B, Casley D J, Bach L A, Kelly D J, Gilbert R E. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999; 48: 2229–2239
   PubMed Web of Science ®Google Scholar
• Chen S, Kasama Y, Lee J S, Jim B, Marin M, Ziyadeh F N. Podocyte-derived vascular endothelial growth factor mediates the stimulation of α 3(IV) collagen production by transforming growth factor-β 1 in mouse podocytes. Diabetes 2004; 53: 2939–2949
   PubMed Web of Science ®Google Scholar
• Aaltonen P, Luimula P, Astrom E, Palmen T, Gronholm T, Palojoki E, Jaakkola I, Ahola H, Tikkanen I, Holthofer H. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 2001; 81: 1185–1190
   PubMed Web of Science ®Google Scholar
• Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, Camussi G. Nephrin expression is reduced in human diabetic nephropathy. Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52: 1023–1030
   PubMed Web of Science ®Google Scholar
• Benigni A, Gagliardini E, Tomasoni S, Abbate M, Ruggenenti P, Kalluri R, Remuzzi G. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 2004; 65: 2193–2200
   PubMed Web of Science ®Google Scholar
• Langham R G, Kelly D J, Cox A J, Gow A J, Holthofer H, Gilbert R E. Angiotensin II-induced proteinuria and expression of the podocyte slit pore membrane protein, nephrin. Nephrol Dial Transplant 2004; 19: 262–263
   PubMedGoogle Scholar
• Palmen T, Ahola H, Palgi J, Aaltonen P, Luimula P, Wang S, Jaakkola I, Knip M, Otonkoski T, Holthofer H. Nephrin is expressed in the pancreatic beta cells. Diabetologia 2001; 44: 1274–1280
   PubMedGoogle Scholar
• Aaltonen P, Rinta-Valkama J, Patari A, Tossavainen P, Palmen T, Kulmala P, Knip M, Holthofer H. Circulating antibodies to nephrin in patients with type 1 diabetes. Nephrol Dial Transplant 2007; 22: 146–153
   PubMedGoogle Scholar
• Jafar T H, Stark P C, Schmid C H, Landa M, Maschio G, Marcantoni C, de Jong P E, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey A S, AIPRD Study Group (Angiotensin-Converting Enzyme Inhibition and Progression of Renal Disease). Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001; 60: 1131–1140
   PubMed Web of Science ®Google Scholar
• Gansevoort R T, Sluiter W J, Hemmelder M H, de Zeeuw D, de Jong P E. Antiproteinuric effect of blood-pressure-lowering agents: a metaanalysis of comparative trials. Nephrol Dial Transplant 1995; 10: 1963–1974
   PubMed Web of Science ®Google Scholar
• Don B R, Kaysen G A, Huchison F N, Schambelan M. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. Am J Kidney Dis 1991; 17: 10–17
   PubMedGoogle Scholar
• Liebau M C, Lang D, Bohm J, Endlich N, Bek M J, Witherden I, Mathieson P W, Saleem M A, Pavenstadt H, Fischer K G. Functional expression of the renin angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006; 27: F710–F719
   Google Scholar
• Adamczak M, Gross M L, Krtil J, Koch A, Tyralla K, Amann K, Ritz E. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 2003; 14: 2833–2842
   PubMed Web of Science ®Google Scholar
• Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 2007; 49: 355–364
   PubMed Web of Science ®Google Scholar
• Amann K, Nichols C, Tornig J, Schwarz U, Zeier M, Mall G, Ritz E. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental chronic renal failure. Nephrol Dial Transplant 1996; 11: 1003–1011
   PubMedGoogle Scholar
• Yamauchi K, Takano Y, Kasai A, Hayakawa K, Hiramatsu N, Enomoto N, Yao J, Kitamura M. Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes. Kidney Int 2006; 70: 892–900
   PubMedGoogle Scholar
• Moreno-Manzano V, Mampaso F, Sepulveda-Munoz J C, Alique M, Chen S, Ziyadeh F N, Iglesias-de la Cruz M C, Rodriguez J, Nieto E, Orellana J M, Reyes P, Ambas I, Xu Q, Kitamura M, Lucio Cazana F J. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol 2003; 139: 823–831
   PubMed Web of Science ®Google Scholar
• He J C, Lu T C, Fleet M, Sunamoto M, Husain M, Fang W, Neves S, Chen Y, Shankland S, Iyengar R, Klotman P E. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J Am Soc Nephrol 2007; 18: 93–102
   PubMed Web of Science ®Google Scholar
• Kuhlmann A, Haas C S, Gross M L, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K. 1,25-dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 2004; 286: F526–F533
   PubMed Web of Science ®Google Scholar
• Ransom R F, Lam N G, Hallett M A, Atkinson S J, Smoyer W E. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 2005; 68: 2473–2483
   PubMed Web of Science ®Google Scholar
• Ransom R F, Vega-Warner V, Smoyer W E, Klein J. Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int 2005; 67: 1275–1285
   PubMedGoogle Scholar
• Miyata T, Inagi R, Sugiyama S, Usuda N. Serpinopathy and endoplasmic reticulum stress. Med Mol Morphol 2005; 38: 73–78
   PubMedGoogle Scholar
• Inagi R, Nangaku M, Onogi H, Ueyama H, Kitao Y, Nakazato K, Ogawa S, Kurokawa K, Couser W G, Miyata T. Involvement of endoplasmic reticulum (ER) stress in podocyte injury by excessive protein accumulation. Kidney Int 2005; 68: 2639–2650
   PubMed Web of Science ®Google Scholar
• Fujii Y, Khoshnoodi J, Takenaka H, Hosoyamada M, Nakajo A, Bessho F, Kudo A, Takahashi S, Arimura Y, Yamada A, Nagasawa T, Ruotsalainen V, Tryggvason K, Lee A S, Yan K. The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases. Kidney Int 2006; 69: 1350–1359
   PubMed Web of Science ®Google Scholar
• Kim B S, Park H C, Kang S W, Choi K H, Ha S K, Han D S, Lee H Y. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis in rats. Yonsei Med J 2005; 46: 141–148
   PubMedGoogle Scholar
• Zima T, Tesar V, Stipek S, Crkovska J, Poledne R, Teminova J, Platenik J, Rychlik I, Merta M, Nemecek K. The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron 1997; 75: 464–468
   PubMed Web of Science ®Google Scholar
• Hocker B, Knuppel T, Waldherr R, Schaefer F, Weber S, Tonshoff B. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 2006; 21: 1476–1479
   PubMedGoogle Scholar
• Daniel C, Renders L, Amann K, Schulze-Lohoff E, Hauser I A, Hugo C. Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat. Am J Transplant 2005; 5: 2849–2861
   PubMed Web of Science ®Google Scholar
• Cho M E, Hurley J K, Kopp J B. Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity. Am J Kidney Dis 2007; 49: 310–317
   PubMed Web of Science ®Google Scholar
• Tonolo G, Velussi M, Brocco E, Abaterusso C, Carraro A, Morgia G, Satta A, Faedda R, Abhyankar A, Luthman H, Nosadini R. Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes. Kidney Int 2006; 70: 177–186
   PubMed Web of Science ®Google Scholar
• Bussolati B, Deregibus M C, Fonsato V, Doublier S, Spatola T, Procida S, Di Carlo F, Camussi G. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol 2005; 16: 1936–1947
   PubMed Web of Science ®Google Scholar
• Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kidney Int 2002; 61: 1635–1645
   PubMed Web of Science ®Google Scholar
• Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G, Corsonello A, Senatore M, Frisina H. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. Clin Pharmacol Ther 2000; 67: 427–431
   PubMed Web of Science ®Google Scholar
• Nakamura T, Ushiyama C, Suzuki S, Shimada N, Sekizuka K, Ebihara L, Koide H. Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentration in type 2 diabetic patients with microalbuminuria or macroalbuminuria. Diabet Med 2001; 18: 308–313
   PubMedGoogle Scholar
• Agarwal R, Saha C, Battiwal M, Vasavad N, Curley T, Chase S D, Sachs N, Semret M H. A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy. Kidney Int 2005; 68: 285–292
   PubMedGoogle Scholar
• Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Garofano E, Rottoli D, Ito T, Remuzzi G. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-γ agonist: molecular mechanism of the antiproteinuric effect of pioglitazone. J Am Soc Nephrol 2006; 17: 1624–1632
   PubMed Web of Science ®Google Scholar
• Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, Hori M. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol 2003; 14: 981–991
   PubMed Web of Science ®Google Scholar
• Chawla A, Repa J J, Evans R M, Mangelsdorf D J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294: 1866–1870
   PubMed Web of Science ®Google Scholar
• Milovanceva-Popovska M, Kunter U, Ostendorf T, Petermann A, Rong S, Eitner F, Kerjaschki D, Barnett A, Floege J. R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury. Kidney Int 2005; 67: 1362–1370
   PubMedGoogle Scholar
• Durvasula R B, Shankland S J. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens 2006; 15: 1–7
   PubMedGoogle Scholar